{ "verifiedOn": "2026-11-06", "compound": "Sermorelin peptide", "slug": "sermorelin", "products": [ { "ingredientIdentity": "Sermorelin; GHRH(1–29)-NH₂; GRF(1–29), a 29-amino-acid peptide with a C-terminal amide", "casNumber": "86168-78-7", "formula": "C149H246N44O42S", "theoreticalMolecularMassDa": 3357.9, "sequence": "H-YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH₂", "counterIon": null, "unitCount": 1, "photoFile": null, "price": null, "checkoutUrl": null, "availability": null, "additionalAccessories": null, "coaId": "sermorelin", "coaFile": "sermorelin-lot-pl-2609-098-coa-redacted.pdf", "intendedUse": "Laboratory research material; not a finished approved medicine.", "id": "vial", "title": "Sermorelin 10 mg vial", "shortName": "10 mg vial", "format": "Freeze-dried peptide powder", "totalMg": 10, "amountLabel": "10 mg sermorelin per vial", "ingredientAmountsMg": { "Sermorelin": 10 }, "ingredients": [ "Sermorelin" ], "concentrationMgMl": null, "fillVolumeMl": null, "unitName": "vial", "perUnitMcg": 10000, "preparation": "Powder requires reconstitution. Concentration depends on the final mixed volume.", "mixingRequired": true, "preparationDiluent": null, "preparationDiluentVolumeMl": null, "preparationHandling": "Add the method-specified diluent slowly against the vial wall; do not shake.", "appearance": "White to off-white lyophilized powder or cake", "storage": "Sealed powder: −20°C (−4°F), dry and protected from light. Prepared solution: 2–8°C (36–46°F), light protected, within its method-specific use period.", "storageTemperatureC": [ -20 ], "storageTemperatureF": [ -4 ], "preparedStorageTemperatureC": [ 2, 8 ], "preparedStorageTemperatureF": [ 35.6, 46.4 ], "inUseLimit": null, "lot": "PL-2609-098", "coaLotLinkageConfirmed": true, "displayCoaLabel": "Redacted powder-lot COA", "coaCoverage": "Two sampled powder vials from lot PL-2609-098", "coaScope": "Powder lot PL-2609-098. Reported purity and the printed peak-area calculation disagree; see the COA note below.", "keyDifference": "10 mg of single-ingredient powder; the final solution concentration is set during preparation.", "measurement": "Use the actual final solution concentration to convert a target amount into mL.", "packageContents": [ "One sealed glass vial with a rubber stopper and aluminium crimp" ], "specificationBasis": "Current product specifications and safety data sheet PL-SDS-150, revision 1.0 dated 3 October 2026.", "labelAmountVsAssay": "10 mg is the label claim. The supplied COA has no separate quantitative vial-content assay.", "displayAmount": "10", "displayUnit": "mg sermorelin per vial", "description": "Single-ingredient freeze-dried powder. Final concentration depends on the prepared volume.", "specs": [ [ "Contents", "10 mg sermorelin" ], [ "Format", "White to off-white powder" ], [ "Preparation", "Reconstitution required" ], [ "Sealed storage", "−20°C (−4°F) · dry and dark" ] ] }, { "ingredientIdentity": "Sermorelin; GHRH(1–29)-NH₂; GRF(1–29), a 29-amino-acid peptide with a C-terminal amide", "casNumber": "86168-78-7", "formula": "C149H246N44O42S", "theoreticalMolecularMassDa": 3357.9, "sequence": "H-YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH₂", "counterIon": null, "unitCount": 1, "photoFile": null, "price": null, "checkoutUrl": null, "availability": null, "additionalAccessories": null, "coaId": "sermorelin", "coaFile": "sermorelin-lot-pl-2609-098-coa-redacted.pdf", "intendedUse": "Laboratory research material; not a finished approved medicine.", "id": "pen", "title": "Sermorelin 6 mg prefilled pen", "shortName": "6 mg pen", "format": "Prepared solution in a 3 mL cartridge and pen", "totalMg": 6, "amountLabel": "6 mg sermorelin total · 3 mL · 2 mg/mL", "totalAmountBasis": "Current product specifications and safety data sheet explicitly state 6 mg per 3 mL; 3 mL × 2 mg/mL.", "ingredientAmountsMg": { "Sermorelin": 6 }, "ingredientConcentrationsMgMl": { "Sermorelin": 2 }, "concentrationMgMl": 2, "fillVolumeMl": 3, "percentWeightVolume": 0.2, "unitName": "pen", "perUnitMcg": 6000, "perClickMl": null, "perClickMcg": null, "deviceScale": null, "preparation": "Already dissolved; no water added to the cartridge.", "mixingRequired": false, "ingredients": [ "Sermorelin", "Water", "Benzyl alcohol 0.9% w/v" ], "excipients": [ { "ingredient": "Water", "amount": "Balance of solution" }, { "ingredient": "Benzyl alcohol", "percentWeightVolume": 0.9 } ], "appearance": "Clear colourless to faint-yellow solution", "storage": "2–8°C (36–46°F), capped in the original carton and protected from light. Do not freeze.", "storageTemperatureC": [ 2, 8 ], "storageTemperatureF": [ 35.6, 46.4 ], "discardConditions": "Discard if frozen, cloudy or discoloured.", "inUseLimit": null, "lot": null, "coaLotLinkageConfirmed": false, "displayCoaLabel": "Powder-lot COA reference", "coaCoverage": "Powder-lot reference only; no finished-cartridge report supplied", "coaScope": "Powder-lot reference only. The report does not test the finished pen or establish its lot linkage.", "keyDifference": "6 mg total, already dissolved at 2 mg/mL; 60% of the labelled sermorelin in one 10 mg vial.", "measurement": "Liquid-volume conversion is supported. Product-specific marked-unit and mechanical-click calibration are unconfirmed.", "packageContents": [ "One prefilled 3 mL glass cartridge inside an autoinjector pen" ], "extraNeedleCount": null, "specificationBasis": "Current product specifications and safety data sheet PL-SDS-151, revision 1.0 dated 3 October 2026. No product-specific device-scale calibration supplied.", "labelAmountVsAssay": "6 mg is the stated total. No finished-pen quantitative content assay is supplied.", "displayAmount": "6", "displayUnit": "mg sermorelin per pen", "description": "3 mL of prepared solution at 2 mg/mL. No powder-mixing step.", "specs": [ [ "Cartridge", "3 mL · 2 mg/mL" ], [ "Solution", "Water + 0.9% benzyl alcohol" ], [ "Preparation", "Already mixed" ], [ "Storage", "2–8°C (36–46°F) · do not freeze" ] ] } ], "coas": [ { "id": "sermorelin", "productId": "vial", "displayForProductIds": [ "vial", "pen" ], "title": "Sermorelin — powder lot PL-2609-098", "file": "sermorelin-lot-pl-2609-098-coa-redacted.pdf", "preview": "sermorelin-lot-pl-2609-098-coa-redacted-page-1.png", "pageCount": 2, "lot": "PL-2609-098", "certificateNumber": "PL-26-00098", "labelClaim": "10 mg sermorelin per vial", "sampleDescription": "Lyophilized powder", "purityPercent": 99.63, "purityLabel": "Reported HPLC area purity", "purityMethod": "RP-HPLC, UV 214 nm; main sermorelin peak area as percentage of total integrated peak area", "mainPeakRetentionTimeMin": 6.34, "componentPeakAreasPercent": { "Sermorelin": 99.63 }, "printedMainPeakArea": 4284090, "printedTotalPeakArea": 4306450, "calculatedPurityFromPrintedAreasPercent": 99.48077883175237, "printedAreaPercentTotal": 100.15, "reportConsistencyStatus": "Reported purity and printed peak-area calculation disagree", "purityDiscrepancyNote": "The report states 99.63% purity. Its printed areas give 4,284,090 ÷ 4,306,450 × 100 = 99.48%, and the listed percentages sum to 100.15%. A corrected table or laboratory explanation is needed; the analytical data is unchanged in the redacted copy.", "largestImpurityPercent": 0.19, "largestImpurityRetentionTimeMin": 7.12, "largestImpurityIdentity": "des-Arg29 fragment", "otherPeakAreasPercent": [ { "retentionTimeMin": 5.52, "areaPercent": 0.14 }, { "retentionTimeMin": 6.82, "areaPercent": 0.15 }, { "retentionTimeMin": 7.88, "areaPercent": 0.04 } ], "identityMassDa": { "Sermorelin": 3358.1 }, "theoreticalMassDa": { "Sermorelin": 3357.9 }, "identityMethod": "LC-MS, positive electrospray ionization; stated acceptance within ±1.0 Da of theoretical mass", "sequence": { "Sermorelin": "H-YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH₂" }, "formula": "C149H246N44O42S", "casNumber": "86168-78-7", "waterPercent": 1.8, "waterMethod": "Karl Fischer", "endotoxinEUPerMg": 0.05, "endotoxinSpecificationEUPerMg": "≤5.0", "endotoxinMethod": "Kinetic LAL", "sterilityResult": "No growth; conforms", "sterilityMethod": "USP <71>, membrane filtration; no growth after 14 days", "contentAssay": null, "contentAssayNote": "No separate quantitative vial-content assay is listed. HPLC area purity does not verify the 10 mg fill.", "analysisDate": "2026-09-19", "waterTestDate": "2026-09-20", "endotoxinTestDate": "2026-09-21", "sterilityTestDate": "2026-10-02", "manufacturedDate": "2026-09-18", "issueDate": "2026-10-03", "retestExpiry": "2028-09-18", "unitsInLot": 250, "unitsSampled": 2, "storage": "−20°C (−4°F), desiccated and protected from light.", "laboratoryType": "In-house", "outsideReportsAttached": "None", "conclusion": "PASS stated in the source report; printed purity arithmetic requires clarification.", "scope": "Two sampled powder vials from lot PL-2609-098; no finished-pen testing or lot linkage. The report states 99.63%, but its printed peak areas calculate to 99.48%. The analytical data is unchanged in the redacted copy.", "sha256": "f69344b8161a38fcbba6079f9c6003a4297152d93425a2c8d784c026adfec1b5", "facts": [ [ "Label claim", "10 mg per powder vial" ], [ "LC-MS identity", "3358.1 Da" ], [ "Endotoxin", "0.05 EU/mg" ], [ "Sterility test", "No growth after 14 days" ], [ "Analysis date", "19 September 2026" ], [ "Sampled units", "2 of 250" ] ], "documentTreatment": "Redacted copy: supplier identifiers removed; analytical values, lot, dates and in-house status retained." } ], "unresolvedFacts": [ "Customer selling prices, stock status, checkout destinations and accessory quantities", "Product-specific pen marked-unit and mechanical-click calibration", "Finished-pen batch linkage to powder lot PL-2609-098", "Finished-pen quantitative content, sterility and stability results", "Quantitative vial-content assay and lot-specific counterion", "Validated preparation diluent, final mixing volume and in-use limits", "COA purity discrepancy: stated 99.63%, printed areas calculate to 99.48%, listed percentages sum to 100.15%" ] }